141 / 490
139
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
MONDAY 2 MAY 2016
therapy treatment. This will be followed by the merits of intraprostatic fiducial markers and the potential
for fiducial migration will be analysed. We conclude our session with an overview of shared decision
making and the validation of a decision aid tool for shared decision making in prostate cancer.
Chair: L. Mullaney (Ireland)
Co-chair: C. Dionisi (Italy)
14:30 > Bladder variability for pelvic radiotherapy: its approaches and impact
Speaker: V. Khoo (UK)
SP-0507
15:00 > An evaluation of GoldAnchor intraprostatic fiducial marker stability
during radiotherapy
Speaker: D. Bodusz (Poland)
SP-0508
15:30 > Validation of a prostate cancer decision aid tool for shared decision
making
Speaker: E. Bloemen- van Gurp (The Netherlands)
SP-0509
Poster Viewing
11
CLINICAL: BREAST, HEAD AND NECK
14:30 - 16:00 | POSTER AREA
Chair: V. Grégoire (Belgium)
Chair: A. Fozza (Italy)
> Evaluation of a breast cancer nomogram to predict local relapse after
breast conserving therapy
I. Kindts (Belgium), A. Laenen, S. Peeters, H. Janssen, T. Depuydt,
E. Van Limbergen,
C. Weltens
PV-0510
> Hypofractionated VMAT for early stage breast cancer: acute toxicity and
cosmesis in 840 patients
C. Iftode (Italy), F. De Rose, D. Franceschini, A. Fogliata, E. Villa, A.M.
Ascolese, P. Navarria, G.R. D'Agostino, C. Franzese, T. Comito, A. Tozzi,
E. Clerici, R.L.E. Liardo, A. Stravato, M. Scorsetti
PV-0511
> Accelerated partial breast irradiation for Luminal-A breast cancer: ana-
lysis from a phase 3 trial
I. Meattini (Italy), C. Saieva, I. Desideri, G. Simontacchi, L. Marrazzo,
S. Scoccianti, C. De Luca Cardillo, V. Scotti, P. Bonomo, M. Mangoni,
F. Rossi, J. Nori, D. Casella, M. Bernini, L. Sanchez, L. Orzalesi, S. Pallotta,
S. Bianchi, L. Livi
PV-0512